Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Amphastar Pharmaceuticals, Inc. (AMPH) had Cost of Goods Sold of $100.85M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$171.17M |
|
$6.42M |
|
|
Cost of Goods Sold |
$100.85M |
$70.32M |
|
$157.54M |
|
$13.63M |
|
$-3.58M |
|
$10.05M |
|
$10.05M |
|
$6.42M |
|
$6.42M |
|
$6.42M |
|
$6.42M |
|
$13.63M |
|
$28.74M |
|
45.32M |
|
46.46M |
|
$0.14 |
|
$0.14 |
|
| Balance Sheet Financials | |
$633.68M |
|
$307.23M |
|
$1.01B |
|
$1.65B |
|
$164.48M |
|
$609.80M |
|
$710.29M |
|
$874.77M |
|
$773.39M |
|
$213.77M |
|
$773.39M |
|
44.64M |
|
| Cash Flow Statement Financials | |
$47.84M |
|
$-16.73M |
|
$-30.21M |
|
$170.41M |
|
$171.17M |
|
$0.76M |
|
$9.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
0.44 |
|
0.79 |
|
41.08% |
|
7.96% |
|
7.96% |
|
-- |
|
5.87% |
|
3.75% |
|
$38.33M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.59 |
|
1.09 |
|
82.79 |
|
0.83% |
|
3.00% |
|
0.39% |
|
0.46% |
|
$17.33 |
|
$0.83 |
|
$1.03 |
|